These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1509684)

  • 21. FDA puts forth proposal to mandate patient information.
    Wechsler J
    Formulary; 1995 Oct; 30(10):622-3. PubMed ID: 10151725
    [No Abstract]   [Full Text] [Related]  

  • 22. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report.
    Skelly JP; Van Buskirk GA; Savello DR; Amidon GL; Arbit HM; Dighe S; Fawzi MB; Gonzalez MA; Malick AW; Malinowski H
    J Parenter Sci Technol; 1993; 47(2):52-6. PubMed ID: 8515344
    [No Abstract]   [Full Text] [Related]  

  • 24. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 25. AVMA legislation: partial solution to drug availability problem.
    Gloyd JS
    J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
    [No Abstract]   [Full Text] [Related]  

  • 26. Bar coding: old technology to the rescue.
    Ochs J
    Manag Care; 2003 Jun; 12(6):46-7. PubMed ID: 12854261
    [No Abstract]   [Full Text] [Related]  

  • 27. Medication bar coding and safety reporting to improve patient safety.
    Public Health Rep; 2003; 118(3):275. PubMed ID: 12822186
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

  • 30. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on imprinting.
    Robertson WO; Bobbink S
    Vet Hum Toxicol; 1981; 23(Suppl 1):30. PubMed ID: 7303465
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
    Binder GM
    Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 35. The meaning of FDA approval.
    Fischer RG
    Pediatr Nurs; 1987; 13(5):360. PubMed ID: 3658520
    [No Abstract]   [Full Text] [Related]  

  • 36. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA proposes new rules that would require barcoding and new reporting procedures.
    Healthc Leadersh Manag Rep; 2003 Mar; 11(3):12-3. PubMed ID: 12803025
    [No Abstract]   [Full Text] [Related]  

  • 39. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.